Position in VNRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,743
New position
Shares Held
13,718
first reported quarter
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 31 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026Vanguard Global Advisers, LLC holds $1,494,748,990 across 95 Medical Devices names. VNRX ranks #91 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,890,391 | $399,426,443 | |
| 2 | MDT |
Medtronic plc
|
2,868,614 | $248,565,403 | |
| 3 | SYK |
Stryker Corp
|
753,716 | $247,663,540 | |
| 4 | BSX |
Boston Scientific Corp
|
3,244,238 | $203,575,934 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,269,526 | $101,663,642 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
995,853 | $70,884,816 | |
| 7 | DXCM |
Dexcom Inc
|
842,638 | $52,917,666 | |
| 8 | STE |
STERIS plc
|
214,321 | $47,392,802 |
All Filings in VNRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,743 | 13,718 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||